FIND prices for Primo Star iLED and Country List

Enhancement of diagnostic capacity for TB and MDR-TB is urgently needed to scale-up access to care and treatment of MDR-TB. To help meet this challenge, FIND has collaborated in the development and evaluation of new TB diagnostic tools, including TB liquid culture and DST, rapid species identification, and line probe assay. WHO has officially endorsed the use of these technologies based on the thorough evaluation of the evidence of their effectiveness under actual program conditions. As part of its role in the development and evaluation process of these tools, FIND has successfully negotiated with three of the manufacturing partners to obtain significant price reductions in order to facilitate access to these diagnostic technologies. These discounts average 50% on diagnostic instruments, and 75% on reagents, and are available to high TB burden countries that wish to procure TB diagnostics for use in the public and non-profit health care sectors, and who procure these tools with funding from the government, UNITAID, or the Global Fund.

Current FIND-negotiated prices, along with the list of countries eligible for the discounts, as negotiated by FIND with Carl Zeiss MicroImaging GmbH are listed below:

These prices are FOB at the manufacturer loading bay. In all cases it is recommended that the local Carl Zeiss representative is contacted with respect to additional costs beyond the FOB cost which may include one or more of the following:

Fully landed

The FIND price does include all local costs for local order processing, local warranty ( 1 year) and local after sales service and support, but not for installation and training, special packaging, or financing. Additional transport and shipping (international and local costs), insurance, clearing, customs duties and local taxes, where applicable, as well as the local representative costs are not included. An example is for India, where import duty is 37% if not waived. 

Implementation

The local Carl Zeiss representative can give precise details on all of the above.

Infrastructure

• Laboratory renovation
• Electrical supply, possibly including a backup generator

In addition to these costs, additional investment that is related more generally to establishing fully functional TB laboratory networks should be considered, including;

• Specimen transport costs
• Other essential supplies (gloves, respirators, lab gowns and lab coats)
• Other needed equipment (refrigerated safety centrifuges, freezers, pipettes, etc.)
• Costs related to Quality Assurance
• Laboratory management information system-related costs (LMIS), for inventory management; recording and reporting results.

These should also be taken into consideration when developing budgets and work plans (Figure 1). Guidance is available through the Global Laboratory Initiative and WHO for these areas. 

Countries for which FIND-negotiated prices and the products are available today

* Additions to this country list can be addressed on a case-by-case basis by FIND with the manufacturing partners.